The Faculty of Chemical Engineering and Technology of the University of Zagreb, Croatia, organized the 4th International Symposium on Environmental Management – Towards Circular Economy, SEM2016. The SEM2016 took place on December 7th - 9th, in Zagreb, Croatia, at the Faculty of Chemical Engineering and Technology.
The symposium was an opportunity to exchange the most recent developments achieved in all fields of Environmental Management and Environmental Engineering. The leading scientists, experts and producers of the most advanced technologies, as well as suppliers of modern environmental equipment met at the same place and dealt with the same topics. Scientists and experts presented the latest theories, concepts and practical solutions for environmental management problems through oral and poster presentations. Among the experts Assoc. Prof. Zvjezdana Findrik (UZAG) gave the lecture “Biocatalysis – a nature's way towards green technologies” where the CarbaZymes project had room.
The European Association of Economy and Competitiveness give to Inkemia IUCT group the Gold Medal for Merit in Work in recognition of its professional trajectory, excellent labour during and experience in the Pharmaceutical sector and customer satisfaction for the service provided.
This ceremony was taken place in November at Hotel Westin Palace in Madrid. The distinctions were given by The president of honour of the European Association of Economy and Competitiveness, Hon. Myriam de la Sierra and Urquijo and the price was received by the director of Inkemia Madrid Dr Adrián García on behalf of the CEO Dr Josep Castells.
The Gold Medal for Merit in Work awarded by the AEEC represents excellence and entrepreneurship, contributing to a sustainable and inspiring entrepreneurial European environment, which fosters good economic and social development. By obtaining this award institutions may encourage communication in different professional sectors of convenience as well as a loyalty of your prospects.
During this week two interesting lectures about Industrial Biocatalysis and Biorefineries will take place at UAM facilities and Dr. Pablo Domínguez (CEO & Founder of SUSMOM) will attend as guest speaker. The CEO, and CarbaZyme's participant, is going to share with a wide range of students he's broad knowledge in the field, as well as, he is going to give the attendees an overview of the CarbaZymes project.
Take note of the dates and download the complete programme here.
Title of the lecture: “Industrial Biocatalysis: Some myths dispelled over successful case studies”
Date: 23.11.16 15:30 hrs.
Venue: Faculty of Sciences, UAM Campus, Cantoblanco. Room: 00.307
Abstract: Biocatalysis has gained a space on industrial synthetic chemistry, with several successful cases already being run at commercial level. In this lecture different enzymatic
processes will be described and thoroughly discussed, spanning from proof-of-concept to industrially-sound reaction conditions. Among other enzymes, lyases – catalyzing C-C bond
forming reactions – will play a core role, given their current and future importance at industrial level. The H2020 funded project CarbaZymes – with the goal of boosting lyases to a further
important level at industry – will be presented during the course of the lecture as well.
Title of the lecture: “Biorefineries: From an innovative idea towards (commercial?) development”
Date: 23.11.16 16:30 hrs.
Venue: Faculty of Sciences, UAM Campus, Cantoblanco. Room: 00.307
Abstract: It is presently acknowledged that petroleum resources should be replaced by biobased materials in the coming future, being processed and valorized within the so-called
biorefineries. This paradigm change poses, however, considerable challenges, being petroleum refineries fully optimized and closely integrated, decreasing processing costs to a minimum. In
this lecture, a novel biorefinery concept developed at the university will be shown as case study, with emphasis on options for its potential commercialization. In this way, steps from
academic research (proof-of-concept, patent optimization) to capital raising and set-up of a spin-off will be discussed. The H2020 funded project CarbaZymes – with the goal of taking
biocatalytic processes to a further important level at industry – will be presented during the course of the lecture as well.
The pioneering biotechnology project CarbaZymes, funded with € 8,2 million by the EU’s Horizon 2020 Research and Innovation Programme, held its mid-term review meeting in Brussels in the Mondrian building (CDMA), which houses the Directorate General for Research & Innovation, on 9th September 2016.
Led by the coordinator, Professor W.-D. Fessner from the Technische Universität Darmstadt, PIs, researchers and managers of 7 universities, 6 SMEs and 1 large company met with the Project Officer Dr A. Fuentes and external reviewer Assoc. Professor E. Atanes. The consortium presented its cutting-edge advances of the project so far, which lie in the area of asymmetric C-C bond formation to obtain high value APIs and essential bulk compounds for industry, starting from potentially sustainable, low priced precursors, by applying novel, engineered biocatalysts.
The CarbaZymes Project, with a collective scientific experience of more than 150 years(!) in biocatalysis, aims to revolutionize certain production methods in the chemical industry and then scale them up to demonstration level. After securing IP, these will be ready to be taken up by the relevant industries. The processes of interest to the CarbaZymes platform aspire to be more efficient and more eco-friendly versions of some widely applied conventional organic chemical syntheses, with the aim to replace potential hazards for the benefit of human health and positively impact the future quality of life for European citizens.
The review meeting was highly successful and the CarbaZymes consortium was encouraged to further pursue novel and emerging spin-off developments along with the main goals of the project.
Note to interested parties:
For more information or interviews, please contact the project manager:
On the 2nd and 3rd of June 2016, the Autonomous University of Madrid (Spain) hosted the Progress Meeting of the H2020 CarbaZymes project (www.carbazymes.com). Altogether,40 researchers representing 6 innovative SME´s, 1 industry leader in specialty chemicals and 7 outstanding academic and research organizations from 5 European countries participated.
CarbaZymesis developing advanced methods of biocatalysis using enzymes and microorganisms to catalyze organic synthetic reactions under mild and more sustainable reaction conditions. Carbon-carbon bond forming reactions are key steps in various industrial processes that construct molecules of high value. With a focus on innovation, application and scalability, CarbaZymeshas a genuine practical vision. Its goal is to produce much in demand Active Pharmaceutical Ingredients (API´s) and bulk chemicals, up to the level of demonstration activities planned for large-scale synthesis implementations under industrial settings. The CarbaZymes outcomes will make a significant social and economic impact, by responding efficiently to the needs of an increasing and aging population and by addressing markets worth billions. Moreover, the CarbaZymes project aims to strengthen the global competitiveness of European biotechnology.
During the meeting, successful results were discussed, with outcomes such as the identification of novel enzymes, the optimization of biocatalytic reactions, or the set-up of enzymatic cascades for potential applications. The Consortium´s cutting-edge approach was also demonstrated by three CarbaZymes partners, including The Spanish National Research Council (CSIC),the Technical University of Darmstadt and the SME Sustainable Momentum SL, who have already filed a patent application for a process that is valuable for industrial production. Likewise, other partners are proceeding with patenting of further processes as well. Once IP is secured for future exploitation and value generation, dissemination activities of CarbaZymes come into play. Several publications of the consortium are also in preparation and will be published shortly in high-ranked scientific journals.